Clinical Trial Update: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of Genakumab injections in patients with gout flare has completed, reporting safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Genakumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Acute Gout, Gout Flare | Phase 2 | Status: COMPLETED